Search results for "fusion"

showing 10 items of 4513 documents

The interferance of muscarinic receptors with the noradrenaline release from sympathetic nerve endings caused by nicotinic agents.

1968

medicine.medical_specialtySympathetic nervous systemSympathetic Nervous SystemReceptors DrugIn Vitro TechniquesPiperazinesNorepinephrineInternal medicineMuscarinic acetylcholine receptorMuscarinic acetylcholine receptor M4medicineAnimalsSympathomimeticsPharmacologyNerve EndingsChemistryMyocardiumMuscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M2General MedicineMuscarinic acetylcholine receptor M1AcetylcholinePerfusionEndocrinologymedicine.anatomical_structureRabbitsFree nerve endingAcetylcholinemedicine.drugNaunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie
researchProduct

0110 : Experimental cerebral ischemia in rats increases myocardial vulnerability to ischemia-reperfusion injury ex vivo

2016

For years, the relationship between cardiac and neurological ischemic events has been mainly attributed to overlapping pathophysiological mechanisms and common risk factors. However, acute stroke may induce dramatic alterations of cardiovascular function. The aim of this work was to evaluate how prior cerebrovascular lesions affect myocardial function in vivo and ex vivo , as well as myocardial vulnerability to ischemic injury. Cerebral embolization was performed in adult Wistar male rats by the injection of microspheres into the left internal carotid artery. Left ventricular function, investigated in vivo using echocardiography (1 hour, 24 hours and 7 days after the embolization), was not …

medicine.medical_specialtySympathetic nervous systemmedicine.medical_treatmentIschemia030204 cardiovascular system & hematologycerebral ischemia03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineHeart ratemedicinecardiovascular diseases030212 general & internal medicineEmbolizationStrokeComputingMilieux_MISCELLANEOUSbusiness.industry[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemmedicine.disease3. Good healthEpinephrinemedicine.anatomical_structureAnesthesiaCardiologyCardiology and Cardiovascular MedicinebusinessReperfusion injuryEx vivomedicine.drug
researchProduct

Umbilical artery blood flow velocity waveforms during variable decelerations of the fetal heart rate

1991

Blood flow velocities of the umbilical arteries were measured by Doppler ultrasonography during variable decelerations of the fetal heart rate. The flow velocity waveforms, being normal between uterine contractions, showed either an unchanged flow velocity waveform with an exclusive fetal heart rate effect on end-diastolic velocities or a rapid change to absent and reverse diastolic flow during the decelerations, indicating an abrupt increase in placental resistance with a halt in placental perfusion. Computer-aided reconstruction of the fetal heart rate curve revealed the exact temporal relationship between the reduction of umbilical artery perfusion and deceleration of fetal heart rate. W…

medicine.medical_specialtySystoleDiastoleHemodynamicsUltrasonography PrenatalUmbilical ArteriesUterine ContractionDiastolePregnancyInternal medicinemedicine.arteryHeart ratemedicineHumansUmbilical Cord OcclusionFetusbusiness.industryObstetrics and GynecologyUmbilical arteryBlood flowAnatomyHeart Rate FetalCardiologyFemaleLabor Stage FirstbusinessPerfusionBlood Flow VelocityAmerican Journal of Obstetrics and Gynecology
researchProduct

Cerebral protection against ischemia by locomotor activity in gerbils. Underlying mechanisms.

1995

Background and Purpose A previous communication of this laboratory demonstrated reduced mortality and neuronal damage by spontaneous locomotor activity preceding forebrain ischemia in Mongolian gerbils. The present experiments seek to elucidate potential mechanisms of protection by measurement of cerebral blood flow, cerebral tissue conductance as an indicator of ischemic cell swelling, and the cerebral release of eicosanoids. Methods Gerbils were maintained either in conventional cages (nonrunners) or with free access to running wheels (runners) for 2 weeks preceding 15 minutes of forebrain ischemia. During ischemia and 2.5 hours of reperfusion, cerebral tissue conductance was determined …

medicine.medical_specialtyThromboxaneIschemiaProstaglandinGerbilBrain Ischemiachemistry.chemical_compoundProsencephalonInternal medicinemedicineAnimalsAdvanced and Specialized Nursingbusiness.industrymedicine.diseaseThromboxane B2Thromboxane B2EndocrinologychemistryCerebral blood flowAnesthesiaCerebrovascular CirculationReperfusionProstaglandinsNeurology (clinical)Prostaglandin D2Cardiology and Cardiovascular MedicinebusinessGerbillinaePerfusionLocomotionStroke
researchProduct

The timing of introduction of pharmaceutical innovations in seven European countries

2014

RATIONALE, AIMS AND OBJECTIVES: Differences in the performance of medical care may be due to variation in the introduction and diffusion of medical innovations. The objective of this paper is to compare seven European countries (United Kingdom, the Netherlands, West Germany, France, Spain, Estonia and Sweden) with regard to the year of introduction of six specific pharmaceutical innovations (antiretroviral drugs, cimetidine, tamoxifen, cisplatin, oxalaplatin and cyclosporin) that may have had important population health impacts. METHODS: We collected information on introduction and further diffusion of drugs using searches in the national and international literature, and questionnaires to …

medicine.medical_specialtyTime FactorsAlternative medicinePopulation healthpharmaceuticalsMedical careWest germanyoutcome measuresNursingquality of careSurveys and QuestionnairesInternational literaturemedicineHumansPharmaceutical innovationsSales statisticsDrug ApprovalQuality of Health Carebusiness.industryHealth PolicyPublic Health Environmental and Occupational HealthOriginal ArticlesmortalityClinical trialEuropePharmaceutical Preparationsmedical careDiffusion of Innovationbusinesshealth systemsDemographyJournal of Evaluation in Clinical Practice
researchProduct

Interstitial washout and hydrolysis of acetylcholine in the perfused heart

1982

The efflux of acetylcholine, of radioactively labelled acetylcholine and choline, into the venous effluent of the perfused chicken heart was studied to determine the kinetics of both interstitial washout and hydrolysis of acetylcholine. Stimulation of both cervical vagus nerves (e.g., for 5 s at 40 Hz) caused a release of acetylcholine, which appeared partially unhydrolyzed in the venous effluent, and reduced force of contraction and heart rate. For comparison, labelled acetylcholine or choline was infused for 5 s into the heart and again the venous efflux of either substance was determined. It was found that the kinetics of efflux of acetylcholine or choline from the interstitial space wer…

medicine.medical_specialtyTime FactorsContraction (grammar)StimulationIn Vitro TechniquesCholinechemistry.chemical_compoundInterstitial spaceInternal medicineHeart ratemedicineAnimalsCholineCholinesterasePharmacologybiologyHydrolysisMyocardiumVagus NerveGeneral MedicineAcetylcholineElectric StimulationPerfusionEndocrinologychemistrybiology.proteinChickensPerfusionAcetylcholinemedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

RIPHeart (Remote Ischemic Preconditioning for Heart Surgery) Study: Myocardial Dysfunction, Postoperative Neurocognitive Dysfunction, and 1 Year Foll…

2018

Background Remote ischemic preconditioning ( RIPC ) has been suggested to protect against certain forms of organ injury after cardiac surgery. Previously, we reported the main results of RIPHeart (Remote Ischemic Preconditioning for Heart Surgery) Study, a multicenter trial randomizing 1403 cardiac surgery patients receiving either RIPC or sham‐ RIPC . Methods and Results In this follow‐up paper, we present 1‐year follow‐up of the composite primary end point and its individual components (all‐cause mortality, myocardial infarction, stroke and acute renal failure), in a sub‐group of patients, intraoperative myocardial dysfunction assessed by transesophageal echocardiography and the incidenc…

medicine.medical_specialtyTime FactorsMyocardial InfarctionNeurocognitive DisordersMyocardial Reperfusion InjuryNeuropsychological Tests030204 cardiovascular system & hematologyischemia/reperfusion injuryRisk Assessment03 medical and health sciencesCognition0302 clinical medicineDouble-Blind MethodRisk FactorsIschemiaGermanyMulticenter trialClinical StudiesClinical endpointHumansMedicineProspective Studies030212 general & internal medicineMyocardial infarctionCardiac Surgical ProceduresProspective cohort studyPropofolStrokeOriginal ResearchCardiovascular Surgerycardio‐vascular surgerybusiness.industryIncidenceProtective Factorsmedicine.diseaseSurgeryCardiac surgeryTreatment OutcomeIschemic Preconditioning MyocardialIschemic preconditioningremote ischemic preconditioningCardiology and Cardiovascular MedicinebusinessPropofolAnesthetics IntravenousEchocardiography Transesophagealmedicine.drug
researchProduct

Characterization of choline efflux from the perfused heart at rest and after muscarine receptor activation.

1986

The resting efflux of choline from perfused chicken hearts varied from 0.4 to 2.6 nmol/g min, but was constant for at least 80 min in the individual experiments. The rate of choline efflux was found to be equal to the rate of choline formation in the heart, which, from the following reasons, was essentially due to hydrolysis of choline phospholipids. Cardiac content of choline phospholipids (7,200 nmol/g) was much higher than that of acetylcholine (5.5 nmol/g). Resting release of acetylcholine was 0.016 nmol/g min and, after inhibition of cholinesterase, only about 0.1 nmol/g min. Resting efflux of choline was reduced by mepacrine, a phospholipase A2 inhibitor, by perfusion with a Ca2+-free…

medicine.medical_specialtyTime FactorsOleic AcidsIn Vitro TechniquesCholinechemistry.chemical_compoundInternal medicinemedicineCholineAnimalsMagnesiumPhospholipidsCholinesterasePharmacologyMuscarinebiologyMyocardiumGeneral MedicineIsolated heartMyocardial ContractionReceptors MuscarinicPerfusionEndocrinologychemistryParasympathomimeticsQuinacrinebiology.proteinCalciumEffluxCholine formationReceptor activationChickensAcetylcholinemedicine.drugOleic AcidNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rab…

1996

Objective: The complement system has been suggested to play a role in reperfusion injury which may result from an enhanced destruction of myocardial tissue or from an impairment of reflow. We investigated the influence of the C5b-9 complement complex on infarct size, reflow and arrhythmogenesis. Methods: Twenty-eight C6-competent rabbits and 18 rabbits with congenital C6 deficiency were subjected to either 30 min or 2 h of coronary artery occlusion followed by reperfusion. C6 deficiency was confirmed by the complement titration test and immunohistology. The triphenyl tetrazolium chloride method was used to delineate infarct size. Reflow into infarcted areas was evaluated histologically afte…

medicine.medical_specialtyTime FactorsPhysiologyMyocardial InfarctionIschemiaInfarctionMyocardial Reperfusion InjuryComplement Membrane Attack ComplexElectrocardiographyReperfusion therapyPhysiology (medical)Internal medicinemedicineAnimalscardiovascular diseasesComplement Activationbusiness.industryArrhythmias Cardiacmedicine.diseaseImmunohistochemistryComplement C6Complement systemRegional Blood FlowCoronary occlusionNo reflow phenomenoncardiovascular systemCardiologyRabbitsCardiology and Cardiovascular MedicineComplement membrane attack complexbusinessReperfusion injuryCardiovascular Research
researchProduct

Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-i…

2022

Summary Background Vancomycin is the most widely used antibiotic for neonatal Gram-positive sepsis, but clinical outcome data of dosing strategies are scarce. The NeoVanc programme comprised extensive preclinical studies to inform a randomised controlled trial to assess optimised vancomycin dosing. We compared the efficacy of an optimised regimen to a standard regimen in infants with late onset sepsis that was known or suspected to be caused by Gram-positive microorganisms. Methods NeoVanc was an open-label, multicentre, phase 2b, parallel-group, randomised, non-inferiority trial comparing the efficacy and toxicity of an optimised regimen of vancomycin to a standard regimen in infants aged …

medicine.medical_specialtyTime FactorsPopulationEquivalence Trials as TopicLoading doseArticlelaw.inventionGram-positiveRandomized controlled triallawVancomycinIntensive careInternal medicineIntensive Care Units NeonatalSepsisDevelopmental and Educational PsychologyClinical endpointMedicineHumansDosingeducationInfusions Intravenouseducation.field_of_studybusiness.industryInfant NewbornInfantdosingUnited KingdomAnti-Bacterial AgentsEuropeRegimenTreatment OutcomeSpainRelative riskPediatrics Perinatology and Child Healthsepsibusiness
researchProduct